WASHINGTON, D.C. (Monday, September 14, 2009) - Media registration is now available for the 8th Annual BIO Investor Forum - a national meeting with a special focus on investment strategies and competitive therapeutic and drug development landscapes. The event will take place October 28-29, 2009 at the Palace Hotel in San Francisco, Calif. To register, please visit http://investorforum.bio.org/media.
The BIO Investor Forum will feature more than 110 late stage and emerging public company presentations, partnering meetings, and networking opportunities with investors and executives in the life sciences field.
Highlights for this year’s conference include plenary sessions on sustaining biotech innovation in light of healthcare reform, as well as forecasting key industry and investment catalysts for 2010. Therapeutic workshops will address areas of dynamic pipeline growth including prostate cancer, influenza, autoimmune disease and personalized medicine; and this year’s business roundtables will offer the buyer’s perspective on today’s IPO candidates and prospects, the insider’s view on designing clinical trials that increase deal value, and new deal structures designed to reduce M&A risk.
The BIO Investor Forum is a must attend event for public and private equity investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences.
To learn more about the BIO Investor Forum, including registration and program information, please visit http://investorforum.bio.org/. Registration is complementary for credentialed members of the media.
Upcoming BIO Events
BIO Investor Forum
October 28-29, 2009
San Francisco, CA
Advanced Business Development Course
October 30, 2009
BIO Europe International Partnering Conference
November 2-4, 2009
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.